These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2504638)

  • 1. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
    Chakrabarti S; Sima AA
    Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase and retinal capillary basement membrane thickening.
    Robison WG; Nagata M; Kinoshita JH
    Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
    Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
    Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-rat.
    Chakrabarti S; Sima AA
    Diabetologia; 1987 Dec; 30(12):966-8. PubMed ID: 3125081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
    Osterby R; Gundersen HJ
    J Diabet Complications; 1989; 3(3):149-53. PubMed ID: 2528558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A; Frank RN; Zhang NL; Samadani E
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
    Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
    J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase activity and basement membrane thickening.
    Frank RN
    Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
    Robison WG; Tillis TN; Laver N; Kinoshita JH
    Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant retinal capillary basement membrane thickening in hyperglycemic and normoglycemic diabetic-prone (DP) BB Wistar rats.
    Greenwood MD; Ressler MJ; Audette JL; Laturnus DI; Chhoun R; Teiken JM; Carlson EC
    Ultrastruct Pathol; 2011 Apr; 35(2):97-105. PubMed ID: 21299351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polyol pathway in retinal microangiopathy.
    Robison WG; Kinoshita JH; Kador PF
    Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M; Robison WG
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
    Robison WG
    Adv Exp Med Biol; 1988; 246():365-72. PubMed ID: 3150650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of the BB/W-rat.
    Chakrabarti S; Cherian PV; Sima AA
    Diabetes Res Clin Pract; 1993 May; 20(2):123-8. PubMed ID: 8375264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of basement membrane thickening in diabetic cat retina by sulindac.
    Mansour SZ; Hatchell DL; Chandler D; Saloupis P; Hatchell MC
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):457-63. PubMed ID: 2318584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.